Statement Of Cash Flows [Abstract]

Bayer AG - Filing #6538644

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
1,278,000 EUR
731,000,000 EUR
Adjustments for increase (decrease) in employee benefit liabilities
129,000,000 EUR
295,000,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
6,503,000 EUR
3,056,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) decrease (increase) in short-term deposits and investments
1,828,000 EUR
4,265,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.